uniQure says six data presentations to be delivered at ASGCT.
uniQure announced that six data presentations, of which three are oral presentations, will be delivered at the upcoming American Society of Gene and Cell Therapy 21st Annual Meeting held in Washington D.C., April 29 - May 2, 2019. "We have made significant progress over the past year in advancing our gene therapy expertise through expansion of our research pipeline," stated Sander van Deventer, M.D., Ph.D., chief scientific officer at uniQure. "We are very pleased to have such a strong showing at ASGCT, and to have new preclinical data featured in Huntington's disease, hemophilia A and Fabry disease. We look forward to having these data prominently featured at the conference."
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 15, 2019|
|Previous Article:||Celadon Group divests Logistics business division.|
|Next Article:||Netflix calls lead puts 6:4 into earnings with $26 straddle.|